FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - Börse Stuttgart 07:57:55 06/06/2024 pm IST | ||
| 10.97 EUR | +0.73% |
|
| Current month | +7.65% | ||
| 1 month | +6.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 10.97 | +0.73% |
| 05/24/05 | 10.89 | +7.29% |
| 04/24/04 | 10.15 | +1.60% |
| 03/24/03 | 9.99 | -1.96% |
| 31/24/31 | 10.19 | +0.69% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 07:57 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2WPU |
| ISIN | DE000MG2WPU3 |
| Date issued | 24/04/2024 |
| Strike | 517.4 p |
| Maturity | Unlimited |
| Parity | 0.55 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.06 € |
|---|---|
| Lowest since issue | 9.54 € |
| Spread | 0.03 € |
| Spread % | 0.27% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.23
USD
Average target price
16.45
USD
Spread / Average Target
+24.39%
- Stock Market
- Certificates
- Certificat
